Profile | GDS5420 / 222266_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 1388.31 | 84 |
GSM1296119 | B_lesional_pre-dose | 2072.59 | 90 |
GSM1296076 | C_lesional_pre-dose | 1256.02 | 82 |
GSM1296092 | D_lesional_pre-dose | 735.12 | 74 |
GSM1296103 | E_lesional_pre-dose | 1227.01 | 82 |
GSM1296078 | F_lesional_pre-dose | 1119.23 | 81 |
GSM1296107 | G_lesional_pre-dose | 2672.34 | 92 |
GSM1296109 | H_lesional_pre-dose | 2585.8 | 93 |
GSM1296080 | I_lesional_pre-dose | 746.67 | 74 |
GSM1296090 | J_lesional_pre-dose | 943.01 | 78 |
GSM1296074 | K_lesional_pre-dose | 975.46 | 78 |
GSM1296111 | L_lesional_pre-dose | 2350.07 | 91 |
GSM1296099 | M_lesional_pre-dose | 1079.48 | 80 |
GSM1296086 | O_lesional_pre-dose | 840.17 | 76 |
GSM1296117 | P_lesional_pre-dose | 2155.03 | 90 |
GSM1296113 | Q_lesional_pre-dose | 2675.55 | 93 |
GSM1296096 | R_lesional_pre-dose | 1003.52 | 79 |
GSM1296105 | S_lesional_pre-dose | 1223.22 | 82 |
GSM1296098 | T_lesional_pre-dose | 1691.66 | 87 |
GSM1296101 | U_lesional_pre-dose | 1231.4 | 83 |
GSM1296121 | V_lesional_pre-dose | 2319.79 | 91 |
GSM1296088 | W_lesional_pre-dose | 862.12 | 76 |
GSM1296082 | X_lesional_pre-dose | 857.2 | 77 |
GSM1296115 | Y_lesional_pre-dose | 2062.85 | 90 |
GSM1296084 | Z_lesional_pre-dose | 996.78 | 79 |
GSM1296072 | B_lesional_day8 | 2281.71 | 91 |
GSM1296069 | L_lesional_day8 | 2479.69 | 92 |
GSM1296071 | P_lesional_day8 | 2554.98 | 93 |
GSM1296070 | Y_lesional_day8 | 2357.67 | 92 |
GSM1296073 | V_lesional_day8 | 1822.13 | 88 |
GSM1296034 | A_lesional_day15 | 1675.23 | 88 |
GSM1296041 | G_lesional_day15 | 2379.21 | 91 |
GSM1296035 | R_lesional_day15 | 958.13 | 78 |
GSM1296038 | U_lesional_day15 | 1478.87 | 85 |
GSM1296047 | B_lesional_day15 | 2396.19 | 92 |
GSM1296039 | E_lesional_day15 | 950.31 | 78 |
GSM1296042 | H_lesional_day15 | 2371.01 | 92 |
GSM1296043 | L_lesional_day15 | 2594.86 | 93 |
GSM1296037 | M_lesional_day15 | 956.08 | 78 |
GSM1296046 | P_lesional_day15 | 2860.52 | 94 |
GSM1296044 | Q_lesional_day15 | 3001.39 | 95 |
GSM1296045 | Y_lesional_day15 | 2390.82 | 92 |
GSM1296025 | C_lesional_day15 | 1612.35 | 86 |
GSM1296033 | D_lesional_day15 | 845.89 | 76 |
GSM1296027 | I_lesional_day15 | 796.35 | 75 |
GSM1296032 | J_lesional_day15 | 969.28 | 78 |
GSM1296024 | K_lesional_day15 | 1448.9 | 84 |
GSM1296031 | W_lesional_day15 | 1012.24 | 79 |
GSM1296028 | X_lesional_day15 | 780.59 | 75 |
GSM1296029 | Z_lesional_day15 | 837.97 | 76 |
GSM1296026 | F_lesional_day15 | 993.89 | 79 |
GSM1296030 | O_lesional_day15 | 627.75 | 71 |
GSM1296040 | S_lesional_day15 | 1142.98 | 81 |
GSM1296036 | T_lesional_day15 | 1868.71 | 89 |
GSM1296048 | V_lesional_day15 | 1806.42 | 88 |
GSM1296059 | A_lesional_day43 | 910.95 | 77 |
GSM1296066 | G_lesional_day43 | 2809.23 | 93 |
GSM1296060 | R_lesional_day43 | 977.13 | 79 |
GSM1296063 | U_lesional_day43 | 1077.42 | 80 |
GSM1296064 | E_lesional_day43 | 1121.5 | 81 |
GSM1296067 | H_lesional_day43 | 2722.64 | 94 |
GSM1296062 | M_lesional_day43 | 951.23 | 78 |
GSM1296068 | Q_lesional_day43 | 2913.73 | 95 |
GSM1296050 | C_lesional_day43 | 1392.51 | 84 |
GSM1296057 | D_lesional_day43 | 880.2 | 77 |
GSM1296052 | I_lesional_day43 | 721.08 | 74 |
GSM1296054 | J_lesional_day43 | 1134.64 | 81 |
GSM1296049 | K_lesional_day43 | 1310.61 | 83 |
GSM1296055 | W_lesional_day43 | 1079.23 | 80 |
GSM1296053 | X_lesional_day43 | 775.33 | 75 |
GSM1296058 | Z_lesional_day43 | 712.79 | 73 |
GSM1296051 | F_lesional_day43 | 1041.65 | 80 |
GSM1296056 | O_lesional_day43 | 706.07 | 74 |
GSM1296065 | S_lesional_day43 | 1177.92 | 82 |
GSM1296061 | T_lesional_day43 | 1567.27 | 86 |
GSM1296095 | A_non-lesional_pre-dose | 1323.15 | 83 |
GSM1296120 | B_non-lesional_pre-dose | 2464.27 | 92 |
GSM1296077 | C_non-lesional_pre-dose | 1960.01 | 89 |
GSM1296093 | D_non-lesional_pre-dose | 953.33 | 78 |
GSM1296104 | E_non-lesional_pre-dose | 1170.08 | 82 |
GSM1296079 | F_non-lesional_pre-dose | 1112.15 | 81 |
GSM1296108 | G_non-lesional_pre-dose | 3325.53 | 95 |
GSM1296110 | H_non-lesional_pre-dose | 3495.47 | 96 |
GSM1296081 | I_non-lesional_pre-dose | 699.17 | 73 |
GSM1296091 | J_non-lesional_pre-dose | 1047.82 | 79 |
GSM1296075 | K_non-lesional_pre-dose | 1293.08 | 83 |
GSM1296112 | L_non-lesional_pre-dose | 2856.12 | 94 |
GSM1296100 | M_non-lesional_pre-dose | 1113.91 | 81 |
GSM1296087 | O_non-lesional_pre-dose | 727.62 | 74 |
GSM1296118 | P_non-lesional_pre-dose | 3268.6 | 96 |
GSM1296114 | Q_non-lesional_pre-dose | 3561.03 | 96 |
GSM1296097 | R_non-lesional_pre-dose | 1261.1 | 83 |
GSM1296106 | S_non-lesional_pre-dose | 1531.56 | 86 |
GSM1296102 | U_non-lesional_pre-dose | 1145.38 | 81 |
GSM1296122 | V_non-lesional_pre-dose | 2115.58 | 90 |
GSM1296089 | W_non-lesional_pre-dose | 1255.23 | 83 |
GSM1296083 | X_non-lesional_pre-dose | 636.38 | 71 |
GSM1296116 | Y_non-lesional_pre-dose | 3246.11 | 95 |
GSM1296085 | Z_non-lesional_pre-dose | 814.2 | 76 |